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Oxygen-derived free radicals such as hydroxyl and hydroperoxyl species have been
shown to oxidize phospholipids and other membrane lipid components leading to lipid
peroxidation. In the eye, lipid peroxidation has been reported to play an important role
in degenerative ocular diseases (age-related macular degeneration, cataract, glaucoma,
diabetic retinopathy). Indeed, ocular tissues are prone to damage from reactive oxygen
species due to stress from constant exposure of the eye to sunlight, atmospheric oxygen
and environmental chemicals. Furthermore, free radical catalyzed peroxidation of long
chain polyunsaturated acids (LCPUFAs) such as arachidonic acid and docosahexaenoic acid
leads to generation of LCPUFA metabolites including isoprostanes and neuroprostanes
that may further exert pharmacological/toxicological actions in ocular tissues. Evidence
from literature supports the presence of endogenous defense mechanisms against
reactive oxygen species in the eye, thereby presenting new avenues for the prevention
and treatment of ocular degeneration. Hydrogen peroxide (H2O2) and synthetic peroxides
can exert pharmacological and toxicological effects on tissues of the anterior uvea of
several mammalian species. There is evidence suggesting that the retina, especially retinal
ganglion cells can exhibit unique characteristics of antioxidant defense mechanisms. In
the posterior segment of the eye, H2O2 and synthetic peroxides produce an inhibitory
action on glutamate release (using [3H]-D-aspartate as a marker), in vitro and on the
endogenous glutamate and glycine concentrations in vivo. In addition to peroxides,
isoprostanes can elicit both excitatory and inhibitory effects on norepinephrine (NE)
release from sympathetic nerves in isolated mammalian iris ciliary bodies. Whereas
isoprostanes attenuate dopamine release from mammalian neural retina, in vitro, these
novel arachidonic acid metabolites exhibit a biphasic regulatory effect on glutamate release
from retina and can regulate amino acid neurotransmitter metabolismwithout inducing cell
death in the retina. Furthermore, there appears to be an inhibitory role for neuroprostanes
in the release of excitatory amino acid neurotransmitters in mammalian retina. The ability
of peroxides and metabolites of LCPUFA to alter the integrity of neurotransmitter pools
provides new potential target sites and pathways for the treatment of degenerative ocular
diseases.
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INTRODUCTION
Oxidative damage is involved in the pathogenesis of a variety of
chronic degenerative and neurodegenerative diseases. Increasing
evidence indicates that oxidative stress (OS) plays a major role
in ocular pathologies including cataract, age-related macular
degeneration (ARMD), glaucoma, and diabetic retinopathy (DR).
Under normal physiological states, ocular tissues possess sev-
eral intrinsic antioxidant enzymes to cope with OS formed as a
consequence of normal metabolism. During ocular injuries, over-
production of reactive oxygen species (ROS) and free radicals
overwhelms the intrinsic antioxidant mechanisms resulting in OS
and ultimately development of a pathological condition. There
is evidence that products of oxygen-derived free radical pathway
such as peroxides and metabolites of long chain polyunsaturated
fatty acids (LCPUFAs) are involved in oxidative reactions in the
eye and play major roles in the pathogenesis of most ocular dis-
eases (Greene and Paller, 1992; van Reyk et al., 2003; Shichi,
2004; Sangiovanni and Chew, 2005). LCPUFAs are essential struc-
tural components of membrane lipids that are involved in several
physiological functions in the body, including central nervous
system function and development, inflammation, and immuno-
logical responses in the cardiovascular system, amongst other
things (De et al., 1994; Grimble, 1998; Wu and Meydani, 1998).
In the eye, deficiency of docosahexaenoic acid (DHA), the most
abundant LCPUFA, is associated with abnormalities in the visual
system, including retinitis pigmentosa, peroxisomal disorders and
compromised growth and development in infants (Sangiovanni
and Chew, 2005). Tissue damage by oxygen-derived free radicals
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has been associated with a variety of pathological conditions in
the eye. For instance, hydrogen peroxide (H2O2) a biologically
derived stable oxidant intermediate, and other peroxide-induced
radicals can inflict damage on ocular tissues by disrupting cellular
structure and function (Wielgus and Sarna, 2008). In addition, to
their patho-physiological role in the eye, oxidant-derivedmetabo-
lites can exert pharmacological actions on tissues of the anterior
uvea and retina. This review summarizes our current state of
knowledge of the contributions of lipid peroxidation to the patho-
genesis of ocular disorders as well as their pharmacological impact
in the eye.
OXIDATIVE STRESS AND OCULAR DEGENERATIVE DISEASES
The eye is constantly exposed to radiation, atmospheric oxygen,
environmental chemicals, and physical abrasion, thus, creating an
environment that supports generation of elevated levels of ROS
(Green, 1995; van Reyk et al., 2003). Evidence from literature sup-
ports a role for excess free radicals in ocular tissues serving as an
underlying pathology in diseases such as cataracts, ARMD, glau-
coma, and various forms of retinopathy (Green, 1995; Osborne
et al., 1999; Shichi, 2004). The biological role of ROS in some
ocular diseases is summarized below.
CATARACT
Cataract is an ocular disease that is characterized by increas-
ing opacity of the lens resulting in visual impairment (Brennan
and Kantorow, 2009; Sacca et al., 2009). Incidence of cataract
increases with age and is one of the leading causes of blindness
and visual impairment in elderly populations in developing coun-
tries (Li et al., 2009; Sacca et al., 2009). Aging is one of the greatest
risk factors for non-congenital cataract formation, but other fac-
tors include gender, exposure to UV light, cigarette smoking,
increase in ROS, decrease in antioxidant defense, and DNA dam-
age (Brennan and Kantorow, 2009; Li et al., 2009; Sacca et al.,
2009).
OS is a well-documented mechanism involved in cataract pro-
gression in which there is prevalent oxidation of lens DNA,
proteins, and lipids (Sacca et al., 2009). There is evidence that
ROS−•OH,O2• - or H2O2—can damage the lens and contribute
to cataract formation (Berthoud and Beyer, 2009). Moreover,
there are studies in literature showing involvement of reactive
nitrogen species (RNS), such as nitric oxide (NO) in cataract
formation (Varma and Hegde, 2007). Furthermore, iron has the
ability to catalyze free radical reactions, thereby propagating OS.
Peroxidation of lipids is another cause of cataracts formation,
impairing lipid-lipid and protein-lipid interactions particularly
in the lenticular fiber membranes (Sacca et al., 2009). Elevated
levels of hydroperoxides, diene conjugates, and oxy-derivatives of
phospholipid fatty acids have been found in human lenses and
aqueous humor (AH) of patients with complicated and senile
cataracts (Sacca et al., 2009). Lipid peroxidation within cells
decreases glutathione (GSH) and leads to DNA impairment while
lipid hydroperoxidation alters membrane permeability, structure,
and microviscosity of lipid-protein mediums (Sacca et al., 2009).
A study by Li et al., has reported significantly higher plasma
concentrations of (Z,E) isomers of hydroxyoctadecadienoic acid
(HODE), oxidation products of linoleic acid, in subjects with
early cataract indicating that lipid peroxidation plays a role in the
progression of lens opaqueness (Li et al., 2009).
The endogenous antioxidant defense enzymes like catalase
(CAT), GSH peroxidase (GPx), superoxide dismutase (SOD), and
peroxiredoxins operate to balance levels of ROS in the lens. For
example, GSH neutralizes H2O2, lipid peroxides, dihydroascorbic
acid, and prevents formation of disulfide bonds by keeping thiols
in the reduced state. Cysteine and methionine residues also func-
tion as antioxidants through reversible protein oxidation. Thus,
under normal physiological conditions, the lens is able to protect
itself from OS stimuli.
GLAUCOMA
Glaucoma refers to a diverse group of ocular disorders that are
characterized by retinal neurodegeneration, visual field defects
and blindness. Affecting approximately 60 million people glob-
ally, glaucoma is ranked as the second leading cause of irreversible
blindness worldwide. This disease accounts for 9–12% of all cases
of blindness in the US. Open angle glaucoma (POAG), the most
prevalent form of this disease, affects about 95% of all glaucoma’s
encountered in US (Sommer et al., 1991). Although elevated
intraocular pressure (IOP) is the major risk factor for POAG,
a small population of patients exhibit visual defects with nor-
mal IOP—a condition termed normal-tension glaucoma. Thus,
IOP elevation does not singularly account for the clinical mani-
festation of the POAG (Collaborative Normal-Tension Glaucoma
Study Group, 1998; The AGIS Investigators, 2000). The etiology
of POAG is attributed to multifactorial mechanisms, including
OS, ischemia, vascular dysregulation, and altered NOmetabolism
(Sacca et al., 2007; Resch et al., 2009).
OS has been hypothesized to play a significant role in the
pathogenesis of POAG (Alvarado et al., 1981, 1984). Indeed,
both experimental and clinical studies implicate OS in the patho-
genesis of POAG. Targets for OS include trabecular meshwork
(TM) structures in the anterior segment and retinal ganglion
cells (RGCs) and the optic nerve head (ONH) structures in the
posterior segment of the eye. Although the exact outflow mecha-
nism has not been completely elucidated, TM cells regulate AH
outflow as part of the conventional outflow pathway and for-
mation and turnover of extracellular matrix (ECM) (Yue, 1996).
Physiological functions of both TM and Schlemm’s canal decline
with aging, a process that is characterized by an increase in oxi-
dant stress (Grierson et al., 1984; Grierson and Howes, 1987).
OS elicits TM degeneration and confers structural alterations in
TM cytoskeleton, thereby compromising its physiological func-
tions (Zhou et al., 1999). In support of this observation, POAG
patients had higher concentrations of lipid peroxidation prod-
ucts in TM and AH, compared to control subjects (Babizhayev
and Bunin, 1989). In the posterior segment, constant light-
exposure of the LCPUFA-rich retina renders it highly susceptible
to OS. Numerous OS biomarkers have been identified, including
4-hydroxy-2-nonenal (4-HNE), and malondialdehyde (MDA).
Indeed, 4-HNE has been reported to induce apoptosis in pri-
mary cultures of normal ONH astrocytes in humans (Malone and
Hernandez, 2007). Furthermore, MDA was elevated in vitreous
and retina of ocular hypertensive rats, suggesting the presence of
OSmechanisms in those tissues (Ko et al., 2005; Yucel et al., 2005).
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Effective defense mechanisms against free radicals are present
in biological systems. In the eye, ascorbic acid which is found in
high concentrations in both the anterior and posterior segment
of the eye, has been shown to be involved in ocular protection
(Izzotti et al., 2006). Reduced GSH is another prominent antiox-
idant found in the eye that protects ocular tissues from damage
caused by ROS (Riley, 1990; Costarides et al., 1991). High GSH
concentrations can be found in the AH and TM of normal mam-
malian eyes (Kahn et al., 1983). There are findings that also
suggest an antioxidant defense system in the aqueous outflow
system (Ferreira et al., 2004; Yang, 2004; Gherghel et al., 2005).
The retina possesses endogenous self-protective mechanisms such
as the upregulation of pro-survival brain-derived neurotrophic
factor (BDNF) and tyrosine kinase (TRK) receptors, expression
of anti-apoptic Bcl-2 and BCL-x genes and increased expression
of heat shock proteins (HSPs) (Gao et al., 1997; Levin et al.,
1997; Chaudhary et al., 1999; Cui et al., 2002; Huang et al.,
2007). The glial cells and ONH astrocytes are well-equipped
with efficient antioxidant defense mechanism for self-protection
against oxidative damage (Malone and Hernandez, 2007). These
cells upregulate survival-promoting signals against ROS-induced
OS and secrete neurotrophic factors that support RGC axonal
regeneration (Qu et al., 2010). Clearly, endogenous defensemech-
anisms exist in both anterior and posterior segments to protect
the eye against ROS induced damage associated with glaucoma.
AGE-RELATED MACULAR DEGENERATION
ARMD is characterized by irreversible loss of central vision. It
is the leading cause of vision impairment and blindness in per-
sons aged 65 and over in industrialized countries (Ethen et al.,
2007; Hollyfield et al., 2008; Hollyfield, 2010). The disease affects
the macula at the center of the eye and as a consequence results
in loss of central vision which significantly impacts the patient’s
ability to read, watch television or drive (Jarrett and Boulton,
2012) Risk factors that contribute to ARMD are heterogeneous,
mainly including increasing age and different genetic predispo-
sitions, together with several environmental/epigenetic factors
such as cigarette smoking, dietary habits, and phototoxic expo-
sure. In the aging retina, free radicals and oxidized lipoproteins
are considered to be major causes of tissue stress resulting in
local triggers for para-inflammation, a chronic status which con-
tributes to initiation and/or progression of ARMD (Parmeggiani
et al., 2012).
Although the development of ARMD is not clearly under-
stood, OS appears to be one feasible pathway (Winkler et al., 1999;
Kasahara et al., 2005; Ethen et al., 2007; Bertram et al., 2009;
Bruban et al., 2009; Hollyfield, 2010). The death of retinal pig-
ment epithelial (RPE) cells due to OS are the primary targets
in the early phase of ARMD (Kasahara et al., 2005). RPE cells
are transporters of selective molecules between choroidal blood
and the neural retina thereby making their death a prime factor
in accompanying photoreceptor damage (Kasahara et al., 2005).
Indeed, OS may cause injury to the RPE cells, the Bruch’s mem-
brane, and the choroid, which are layers in the eye involved in the
pathophysiology of ARMD (Yildirim et al., 2011). OS in ocular
tissues and accumulation of lipofuscin in the RPE may induce
production of ROS leading to lipid peroxidation and eventual
RPE cell death (Winkler et al., 1999).
Multiple defense mechanisms exist in the retina to combat
OS. Endogenous antioxidants, like non-enzymatic scavengers as
GSH and antioxidant enzymes such as SOD, GPx, and CAT,
are the first lines of endogenous defense against OS and act by
scavenging potentially damaging free radical moieties (Yildirim
et al., 2011). Dietary antioxidants like the carotenoids, vitamins
A, C, and E, selenium, zinc, and bioflavonoids showed decreased
risk of vision loss in ARMD (Winkler et al., 1999; O’Connell
et al., 2008). Clearly, opportunities exist for further investi-
gation of preventive and therapeutic measures against ARMD
that reflect the pathways of disease progression and natural
defense systems.
DIABETIC RETINOPATHY
DR is an ocular neuropathy associated with advanced forms
of both diabetes types I and II (Kanwar et al., 2007; Madsen-
Bouterse and Kowluru, 2008). In spite of advancement in research
techniques, increased emphasis on diabetes prevention and ther-
apeutic monitoring, DR remains an important complication of
diabetes and a leading cause of blindness among young, working-
age adults between 20 and 74 years (Centers for Disease Control
and Prevention, 2013). Clinical appearance of DR is preceded by
biochemical, molecular and hemodynamic alterations that begin
early in the disease process. Both clinical and experimental data
have confirmed the role of chronic hyperglycemia as the major
initiating parameter in the pathogenesis of diabetes complica-
tions (Kaiser et al., 1993; Kuusisto et al., 1994; Ohkubo et al.,
1995; Skyler, 1996). It appears that chronic hyperglycemia elic-
its a series of deleterious alterations that culminate in structural
and functional damage to retina. Evidence suggests a prominent
role for OS in hyperglycemia-induced alterations in DR patients
and experimental animals (Yadav et al., 1997a,b; Gurler et al.,
2000). While diabetes patients have elevated plasma OS biomark-
ers compared to normal subjects, DR patients exhibit higher
concentrations of OS biomarkers than diabetes patients with-
out DR, suggesting the significance of OS in the pathogenesis of
DR (Gurler et al., 2000). It has been argued that not only does
chronic hyperglycemia generate ROS, but it sets in motion sev-
eral pathways including, activation of aldose reductase (sorbitol),
protein kinase C (PKC), accumulation of advanced glycation-
end-products (AGE) and release of inflammatory mediators and
vascular endothelial-derived growth factor (VEGF) that further
increases OS and concomitantly impairs endogenous antioxidant
defense mechanisms (Al-Shabrawey and Smith, 2010; Cheung
et al., 2010). Thus, OS is a vital parameter that links hyper-
glycemia and evolvement of DR in diabetic subjects (Kanwar
et al., 2007; Madsen-Bouterse and Kowluru, 2008; Pan et al., 2008;
Zheng and Kern, 2009).
Patients with diabetes also show increased production of lipid
peroxidation, DNA damage, and protein oxidation due to OS.
Indeed evidence shows elevated levels of OS biomarkers such
as malondialdehyde,8-isoprostane (IsoP) E2, F2-IsoP, and lipid
hydroperoxides in plasma of diabetic patients (Pan et al., 2008).
Because the retina is rich in PUFAs and has increased glucose
oxidation and oxygen uptake, it is susceptible to increased OS
in hyperglycemia (Madsen-Bouterse and Kowluru, 2008). The
observed structural and functional changes are likely to result
from lipid peroxidation of the vascular endothelium.
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The retina employs a complex antioxidant defense system to
maintain optimal concentrations of NADPH and GSH including
SOD, glucose-6-phosphate dehydrogenase, GPx, GSH reductase,
and CAT (van Reyk et al., 2003; Zheng and Kern, 2009). There is
evidence that DR is associated with reduced levels of GSH, SOD,
CAT, and ascorbic acid (Madsen-Bouterse and Kowluru, 2008).
Furthermore, there are reports that show SOD activity to be
decreased in the vitreous and anterior chamber of hyperglycemic
patients (Zheng and Kern, 2009).
ROLE OF OXIDANT-DERIVED METABOLITES IN
PATHOGENESIS OF EYE DISEASES
Stress induced by oxygen-derived radicals such as hydroxyl rad-
ical, superoxide anion and H2O2 can be deleterious to cells
(Gilgun-Sherki et al., 2002; Blokhina et al., 2003). In the eye,
free radical-induced tissue damage has been associated with a
variety of pathological conditions. H2O2 in particular, has been
reported to be involved in oxidative reactions in ocular tissues,
thus, indicting a possible role for this peroxide in ocular physiol-
ogy and pathology (Ohia et al., 2005). In addition to peroxides,
metabolites of LCPUFA have also been implicated in the pro-
gression of ocular neurodegenerative diseases. LCPUFAs play a
significant structural and physiological role within the cell. Due
to the abundance of double bonds in their structure, these fatty
acids are highly susceptible to lipid peroxidation to form an array
of oxidant-derivedmetabolites. This susceptibility is further com-
pacted in ocular tissues due to constant exposure of the eye to
light and high lipid content in some ocular tissues (Mainster,
1987; Green, 1995; Organisciak et al., 1998; van Reyk et al., 2003).
In spite of evidence depicting the role of OS in ocular pathology,
further research is warranted to fully delineate the physiological
role and biological impact of oxidant-derived metabolites in the
eye. Table 1 provides a summary of oxidant–derived metabolites
present in ocular tissues and their role in ocular pathology.
PEROXIDES
There is evidence that H2O2 and enzymes involved in its
metabolism is present in both the anterior segment and poste-
rior segment of the eye (Rose et al., 1998; Beatty et al., 2000).
H2O2 is continually produced in the AH by cellular metabolism
and exposure to UV light. The concentration of H2O2 in the
AH and anterior uvea in healthy persons is in the range of 30
and 70μM (Rose et al., 1998). In the AH and corneal epithe-
lium, vitamin C reacts with O2 to form H2O2 in protecting the
eye against UV radiation (Izzotti et al., 2009). In the anterior
segment, free radical-induced tissue damage has been associated
with a variety of pathological conditions such as cataract and
experimental autoimmune uveitis (Wu et al., 1997; Shichi, 2004).
In patients with cataract, concentrations of H2O2 that is ten to
thirty-fold higher than healthy human subjects has been reported
in lens and AH (Shichi, 2004; Wielgus and Sarna, 2008). In addi-
tion, there is evidence that lens epithelial cells are exceedingly
susceptible to OS generated by H2O2. Indeed, short term expo-
sure of epithelial cells to 25–50μM H2O2will disturb normal
metabolism, especially if there is a breach in antioxidant defense
(Ma et al., 2004). H2O2 has also been shown to cause DNA
damage in lens and corneal epithelial cells (Atilano et al., 2009).
Exposure of lens epithelial cells to H2O2 causes opacification and
cataract (Jin et al., 2007). The TM of the eye is particularly sen-
sitive to H2O2-induced OS; high concentrations of H2O2 in GSH
compromised eyes leads to reduced outflow in the AH (Izzotti
et al., 2009).
As opposed to the anterior segment of the eye, not much is
known on the role of oxygen-derived free radicals in the posterior
segment of the eye. Hence further studies are needed to under-
stand the biological role of these metabolites in ocular tissues.
In the retina, H2O2 has been linked to damage due to expo-
sure to light and oxygen (Beatty et al., 2000). Both H2O2 and
enzymes that mediate its metabolism are present in the retina
(Liles et al., 1991; Beatty et al., 2000; Sandbach et al., 2001).
Ascorbic acid has been reported to act as an antioxidant for the
removal of H2O2 in ocular tissues including the retina (Shang
et al., 2003). Interestingly, the concentration of ascorbic acid in
the vitreous humor has been reported to be twice that found in
the AH (Rose et al., 1998). The higher levels of ascorbic acid in the
vitreous humor may serve to protect the retina against the dam-
aging effects of OS and ultraviolet radiation. The concentration of
H2O2 in the vitreous humor of human patients with cataract has
been reported to be two to three times more than the amount of
this oxidant found in normal patients (Shichi, 2004). It remains to
be determined if such high levels of H2O2 in the vitreous humor
can also affect normal retinal function.
Table 1 | Summary of several Oxidant-derived metabolites and their role in ocular pathology.
Oxidant-derived
metabolites
Ocular tissue presence Plausible role Associated ocular pathology
PEROXIDES
H2O2 Cataract, uveitis
Hydroperoxides Lens, aqueous humor Disrupt cell function and structure




Lens Membrane permeability alteration, cell
structure changes
Cataract
4-hydroxy-2-nonenal (4-HNE) TM, optic nerve, retina Apoptosis, protein modification Glaucoma, ARMD
Malondialdehyde TM, retina, vitreous humor Cytoskeleton alterations, functional changes Glaucoma
ISOPs Aqueous humor, lens, retina Structural and functional damage to tissue Exfoliation syndrome (XFS), cataract, DR
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LCPUFA PEROXIDATION METABOLITES
The interaction of OS and LCPUFA metabolites is a less known
area of research that could have significant implications in
neuronal tissues. LCPUFA metabolites such as isoprostanes
(IsoPs) and neuroprostanes (NeuroPs) have been shown to
be present in mammalian tissues as well as human biological
fluids (Reich et al., 2000; Cracowski et al., 2002; Fam et al.,
2002; Shichi, 2004). IsoPs are spontaneously derived in abun-
dance in vivo from the LCPUFA, arachidonic acid (AA). These
prostaglandin (PG)-like compounds are produced by the free
radical-catalyzed, non-enzymatic peroxidation of AA. Due to the
fact that IsoPs are stable products, whose production increases
with exposure to OS, they have gained acceptance as a reliable
marker of oxidative injury in both in vivo and in vitro animal
models (Gopaul et al., 1995; Delanty et al., 1997; Morrow, 2000;
Shichi, 2004). Analogous to IsoPs, the NeuroPs are formed by
spontaneous free-radical, non-enzymatic peroxidation of DHA
and have been found to be applicable as diagnostic markers
of oxidative injury (Fam et al., 2002; Shichi, 2004; Morrow,
2006). It has been reported that in the mammalian eye, oxidant
stimuli can increase endogenous production of IsoPs in retina
and AH (Nourooz-Zadeh and Pereira, 2000; Koliakos et al., 2003;
LeDay et al., 2004; Yoshida et al., 2006; Dentchev et al., 2007).
Furthermore, Koliakos et al. showed that the AH of patients with
exfoliation syndrome (XFS) and cataract had an elevated level of
8-isoPGF2α, thus, supporting a role for IsoPs in XFS and cataract
development. When used as an OS marker in ocular studies,
IsoPs levels were significantly higher following tissue exposure
to oxidant stress condition (Dentchev et al., 2007). To the best
of our knowledge there are no reported studies on the role of
neuroprotanes in ocular pathophysiology. Clearly, the need for
more studies in this area of lipidomics could not be overempha-
sized. One can, however, speculate that since prostanoids play
a role in regulation of both inflammatory and neuroprotective
mechanisms in ocular tissues, both IsoPs and NeuroPs could
potentially modulate disease conditions that are characterized by
inflammation and neuronal degradation in the eye.
PHARMACOLOGICAL IMPLICATIONS
Although previously assumed to be inert, it is becoming appar-
ent that oxidant-derived metabolites can exert pharmacological
effects in biological tissues. Due to challenges involved in syn-
thesizing and isolating pure metabolites and the lack of com-
mercially available pure neuroPs and IsoPs, the pharmacological
actions of these lipid metabolites have remained largely unex-
plored. The ability of these metabolites to exert pharmacological
effects in the eye may underlie the mechanism whereby reactive
oxygen metabolites play a role in ocular diseases such as glau-
coma. Further studies are indeed needed to determine the exact
pharmacological role of oxygen-derived free radicals in ocular
diseases.
PEROXIDES
The anterior segment of the eye has the capacity to protect against
deleterious action of oxygen-derive free radicals and is involved
in the metabolism of both endogenous and exogenous H2O2.
Exogenous application of H2O2 and its synthetic peroxides have
been reported to exert pharmacological/toxicological actions on
tissues of the anterior uvea of several mammalian species. Earlier
studies have demonstrated that intracameral injection of H2O2
in the rabbit eye can result in lowered IOP and morpholog-
ical changes in the anterior chamber (Birnbaum et al., 1987;
Csukas and Green, 1988). In addition, H2O2 has been shown to
increase sympathetic neurotransmission in iris-ciliary bodies, an
action that is dependent on the generation of reactive ROS, trace
amounts of extracellular calcium and the functional integrity of
mitochondrial calcium stores (Birnbaum et al., 1987; Csukas and
Green, 1988; Opere and Ohia, 1998). The observed increase of
sympathetic activity could lead to vasoconstriction in the ante-
rior uvea which may cause a reduction in AH production and
consequently a decrease in IOP. There is evidence that PG and
thromboxanes (Tx) canmediate the excitatory effects of peroxides
on sympathetic neurotransmission in mammalian irides and reg-
ulate their inhibitory effects onmuscarinic receptor-induced con-
traction of iris smooth muscle. Graham et al. demonstrated how
the cyclooxygenase (COX) inhibitor flurbiprofen attenuated the
increased action of H2O2 and cumene hydroperoxide (a synthetic
peroxide) on norepinephrine (NE) release (Graham et al., 2000).
The enzyme CAT which is involved in the metabolism of H2O2
has also been linked to neurotransmission regulation by perox-
ides in ocular tissues. Matutte et al. showed that the inhibition of
catalase unmasked an excitatory action of H2O2 on evoked NE
release and an inhibitory effect on muscarinic receptor-induced
contraction of iris smooth muscle (Matutte et al., 2000). These
studies establish that inhibiting peroxide metabolism causes both
sympathetic nerves and smooth muscles of the anterior uvea to
be more susceptible to the harmful effects of H2O2.
The retina is highly susceptible to auto-oxidation via free rad-
ical mechanism due to its high content of polyunsaturated fatty
acids. Peroxides such as H2O2, possess the ability to impair glu-
tamate release. LeDay et al. reported that both H2O2 and cumene
hydroperoxide inhibited potassium-evoked release of glutamate
(using [3H]D-aspartate as a marker) from bovine retinae, a
response prevented by the antioxidant trolox (LeDay et al., 2004).
Furthermore, CAT inhibition enhanced the inhibitory action of
H2O2 on glutamate release. Together these studies indicate that
the inhibitory actions of peroxides on potassium-stimulated glu-
tamate release in the retina is dependent on the generation of
ROS and catalase. In a related study, these workers observed
that peroxides such as H2O2 can decrease both glutamate and
glycine concentrations and that catalase inhibition also caused
a significant reduction in glutamate and glycine concentrations.
Furthermore, LeDay et al. observed that peroxides can directly
stimulate the production of COX and non-COX derived metabo-
lites of the AA pathway and that these products are involved in
mediating the effects of H2O2 on glutamanergic transmission in
the retina (LeDay et al., 2004). These data indicate a vital role for
endogenously produced peroxides in the regulation of amino acid
neurotransmission in the retina.
LCPUFA PEROXIDATION METABOLITES
LCPUFAmetabolites such as IsoPs and NeuroPs have been shown
to exert pharmacological and toxicological effects in ocular tis-
sues. Topical use of 8-iso-PGE2 reduces IOP in normal monkey
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eyes as well as those affected by glaucoma. In addition, there
is evidence that IsoPs can regulate neurotransmission in human
and mammalian ocular tissues. Awe et al. reported that 8-iso-
PGF2α enhances electrically evoked NE release from isolated
human iris-ciliary bodies. This effect is blocked by the throm-
boxane receptor (TP) antagonist SQ-29548 suggesting that TP
receptors mediate the mechanisms of 8-iso-PGF2α. Conversely, 8-
iso-PGE2 was found to inhibit electrically stimulated NE release
from the same tissue, a response that was not affected by SQ-
29548. Taken together, these studies indicate that 8-iso-PGF2α
and 8-iso-PGE2 exert opposing effects on sympathetic neuro-
transmitter in human iris-ciliary bodies via different receptors
or mechanisms (Awe et al., 2000). In contrast, another study by
a different group showed that both 8-iso-PGF2α and 8-iso-PGE2
enhanced electrical-evoked NE release from bovine iris, an action
that was blocked by the TP receptor antagonist SQ-29548 (Awe
et al., 2000; Opere et al., 2001a). These observations support the
view that a species-specific difference in response to IsoPs may
exist in ocular tissues.
In addition to the anterior uvea, IsoPs also regulate neu-
rotransmission in mammalian retina. Liu et al. demonstrated
that IsoPs can attenuate dopamine release from isolated bovine
retina (Liu et al., 2008). There is evidence that the enzymes COX
and Tx synthase may be involved in the effects of IsoPs. The
COX inhibitor, indomethacin has been shown to reduce contrac-
tile response of 8-iso-PGF2α in the retinal vasculature of piglets
and it blocked the excitatory effect of high concentration 8-iso-
PGF2α on [3H]D-aspartate release from bovine retina (Lahaie
et al., 1998; Opere et al., 2005). Studies also report IsoPs are
potent vasoconstrictor of vessels in piglet retina (Lahaie et al.,
1998; Hou et al., 2004). There is evidence that in mammalian
retina, the pharmacological effect of IsoPs involve Tx receptor
(TP) and prostanoid (EP) receptors. Opere et al. showed that
8-iso-PGF2α elicited a dual effect on potassium-induced gluta-
mate release (using [3H]D-aspartate as a marker) from bovine
retina (Lahaie et al., 1998; Opere et al., 2001b; Hou et al., 2004;
Opere et al., 2005, 2008). At low concentrations (1-100nM), 8-
iso-PGF2α activated the PGE receptors (EP) EP1/EP2 to produce
an inhibitory response on glutamate release. Higher concentra-
tions (100nM-30uM) of 8-iso-PGF2α acted upon the TP receptor,
promoting an excitatory effect upon glutamate release. Other
studies also demonstrate that 8-iso-PGE2 exerts its action by
activation of EP receptors because this response was blocked by
EP receptor antagonists SC-19220(EP1), AH-6809(EP1-3), and
AH-23848(EP4) (Zhao et al., 2008, 2009). The pharmacological
actions of neuroPs remain largely unexplored but in preliminary
studies, neuroPs have been shown to exert an excitatory effect
on potassium-evoked glutamate release from bovine retina using
[3H]D-aspartate as a marker. Likewise, intravitreally injected
neuroP enhanced retinal glutamate and glycine levels in bovine
retina (Hou et al., 2004; Opere et al., 2005, 2008; Zhao et al.,
2008, 2009; Jamil et al., 2012). Glutamate is the major excita-
tory amino acid neurotransmitter in the retina and is involved in
the transfer of visual information from the retina to the brain. A
defect in glutamate synaptic transmission and uptake can result
in glutamate neurotoxicity and cell death in the retina (Nucci
et al., 2005; Pulido et al., 2007). Since neuronal excitotoxicity is
preceded by elevation in neuronal glutamate concentrations, the
ability of IsoPs and neuroPs to regulate excitatory neurotransmit-
ter release could have significant pharmacological implications in
mammalian ocular tissues.
PERSPECTIVE
Products of oxygen-derived free radical pathway such as perox-
ides and LCPUFA metabolites are involved in oxidative reactions
in the eye and could play a major role in the pathophysiology of
most ocular diseases. In addition to their pathological roles, these
metabolites can exert pharmacological actions on tissues of the
anterior uvea and retina. The ability of peroxides such as H2O2 to
affect neurotransmitter pools from sympathetic and glutaminer-
gic nerves in the eye may help provide insights on the underlying
mechanism by which ROS contribute to ocular pathologies. It
is well established that OS is an underlying pathology in ocular
neurodegenerative diseases of the eye such as glaucoma and DR.
Since LCPUFAs play a significant role in cellular structure and
signaling, it is necessary to delineate the role of LCPUFA metabo-
lites in the progression of ocular neurodegenerative diseases in the
eye. In spite of current research, the role of lipid metabolites like
NeuroPs and IsoPs in regulation of ocular disease is not yet clear.
It is possible that addition of these lipid by-products to proteins
could serve as diagnostic markers of endogenous peroxidation
status. Furthermore, since numerous stereoisomers and regioiso-
mers of IsoPs and neuroPs can be generated, in vivo, it is possible
that the summation of their effects could significantly impact the
homeostatic environment within the cell. Indeed further research
is warranted to fully delineate the biological significance of these
lipid mediators on biological systems like the eye.
The hypothesized role of oxidation in the development of ocu-
lar diseases has prompted research into the use of antioxidants
as neuroprotective agents in ocular therapy. It is thought that
people with low systemic antioxidant levels may be more prone
to oxidative damage in ocular tissues. As such, substantial body
of research, though controversial indicates that antioxidants can
ameliorate certain common and uncommon ocular conditions.
Despite inconclusive data suggesting that people who eat a diet
rich in antioxidant vitamins such as carotenoids, vitamins C and
E or minerals (selenium and zinc) are less likely to develop certain
ocular diseases, several studies provide evidence supporting a role
for these nutrients in preservation of vision. Indeed vitamins B,
C and selenium have been shown to reduce the risk of cataract
and prevent its development (Rapp et al., 2000; Chiu et al., 2007).
In addition, vitamin E deficiency increases H2O2 levels and the
intracellular production of ROS (Chow et al., 1999). Studies
depict a synergism between vitamin E and C; vitamin C reduces
oxidized vitamin E, which is crucial for protecting cell membranes
from lipid peroxidation (Varma, 1991; Kang et al., 2003). Natural
products such as zinc gluconate, marygold flower extract, ascor-
bic acid, blueberry extract and trans-resveratrol are also known to
have antioxidant effects in the eye and have been used widely to
improve vision and ocular health. Flavonoids and other antioxi-
dants including Ginkgo biloba, Qi Ming granule have been found
to be beneficial in promoting ocular health, and reduce OS in the
eye (Jayle et al., 1965; Urso, 1967; Porcella et al., 2001; Rhee et al.,
2001; Jarvinen et al., 2002; Majumdar and Srirangam, 2010).
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Furthermore, observational and experimental data from the Age-
Related Eye Disease Study (AREDS) suggest that antioxidant
intake may delay progression of ARMD and vision loss (Age-
Related Eye Disease Study Research Group, 2001). Although the
use of antioxidants looks promising for improving outcomes in
ocular disorders, more investigation is warranted in order to stan-
dardize indication for use, composition and dosing for treatment.
At the present time, there remains insufficient scientific data to
recommend routine antioxidant intake for primary prevention of
ocular neuropathies resulting from lipid peroxidation.
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